Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 12
Submit an article Journal homepage
1,744
Views
3
CrossRef citations to date
0
Altmetric
Nephrology

Characteristics of Japanese patients with non-dialysis-dependent chronic kidney disease initiating treatment for anemia: a retrospective real-world database study

Yoshimasa Kokadoa Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2738-7677
ORCID Icon,
Manabu Ishiia Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan
,
Kiichiro Uetaa Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-3489-6971
ORCID Icon,
Hiroyuki Yamamotob Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0003-3337-7595
ORCID Icon,
Hiraku Kumamaruc Department of Healthcare Quality Assessment, Graduate School of Medicine, University of Tokyo, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-9759-6191
ORCID Icon,
Masaaki Isshikid Real World Data Consulting, IQVIA Solutions Japan KK, Tokyo, Japan
,
Sven Demiyad Real World Data Consulting, IQVIA Solutions Japan KK, Tokyo, Japan
&
Hiroaki Miyatab Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan
 show all
Pages 2175-2182 | Received 14 Mar 2022, Accepted 13 Sep 2022, Published online: 11 Oct 2022

References

  • Koury MJ, Haase VH. Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat Rev Nephrol. 2015;11(7):394–410.
  • Mercadal L, Metzger M, Casadevall N, et al. Timing and determinants of erythropoietin deficiency in chronic kidney disease. Clin J Am Soc Nephrol. 2012;7(1):35–42.
  • Panjeta M, Tahirović I, Sofić E, et al. Interpretation of erythropoietin and haemoglobin levels in patients with various stages of chronic kidney disease. J Med Biochem. 2017;36(2):145–152.
  • Astor BC, Muntner P, Levin A, et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002;162(12):1401–1408.
  • Covic A, Jackson J, Hadfield A, et al. Real-world impact of cardiovascular disease and anemia on quality of life and productivity in patients with non-dialysis-dependent chronic kidney disease. Adv Ther. 2017;34(7):1662–1672.
  • McMurray J, Parfrey P, Adamson JW, et al. Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279–335.
  • Tsubakihara Y, Akizawa T, Iwasaki M, et al. High hemoglobin levels maintained by an erythropoiesis-stimulating agent improve renal survival in patients with severe renal impairment. Ther Apher Dial. 2015;19(5):457–465.
  • Japanese Society for Dialysis Therapy. 2008 JSDT “guideline for renal anemia in chronic kidney disease”. J Jpn Soc Dial Ther. 2008;41(10):661–716.
  • Yamamoto H, Nishi S, Tomo T, et al. 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther. 2017;3(1):36.
  • Japanese Society of Nephrology. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Japan J Nephrol. 2012;54(8):1031–1191.
  • Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23(1):1–15.
  • Akizawa T, Makino H, Matsuo S, et al. Management of anemia in chronic kidney disease patients: baseline findings from chronic kidney disease Japan cohort study. Clin Exp Nephrol. 2011;15(2):248–257.
  • Yamamoto T, Miyazaki M, Nakayama M, et al. Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study. Clin Exp Nephrol. 2016;20(4):595–602.
  • Tanaka T, Nangaku M, Imai E, et al. Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan. Clin Exp Nephrol. 2019;23(2):231–243.
  • Hayashi T, Uemura Y, Kumagai M, et al. Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA clinical evidence on renal survival in CKD patients with renal anemia (MIRACLE-CKD study). Clin Exp Nephrol. 2019;23(3):349–361.
  • Sofue T, Nakagawa N, Kanda E, et al. Prevalence of anemia in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan chronic kidney disease database (J-CKD-DB). PLoS One. 2020;15(7):e0236132.
  • Hayashi T, Wada A, Soma A, et al. Randomized therapeutic equivalence study of darbepoetin alfa with epoetin alfa for anemia treatment in chronic kidney disease patients not on dialysis. Kidney Dialy. 2010;68:931–945.
  • Tsubakihara Y, Itami Y, Uda S, et al. Effect of haemoglobin (Hb) maintenance of C.E.R.A. administrated subcutaneously (SC) compared with rHuEPO in chronic kidney disease (CKD) patients not on dialysis. Kidney Dialy. 2011;70:953–963.
  • Ravanan R, Spiro JR, Mathieson PW, et al. Impact of diabetes on haemoglobin levels in renal disease. Diabetologia. 2007;50(1):26–31.
  • Li Vecchi M, Fuiano G, Francesco M, et al. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency. Nephron Clin Pract. 2007;105(2):c62–c67.
  • Akizawa T, Tsubakihara Y, Hirakata H, et al. A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM study. Clin Exp Nephrol. 2016;20(6):885–895.
  • Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085–2098.
  • Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019–2032.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.